Nonclinical safety studies are a critical component of the drug development process. They involve the use of animal models to assess the potential toxicity of a drug before it is tested in humans. These studies help identify potential adverse effects and establish safe dosage levels. ICH guidelines provide detailed recommendations on the design, conduct, and interpretation of these studies to ensure that they provide reliable and relevant data.
